Clinical Trial Update: Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating Lingzhi for slowing disease progression in untreated early Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lingzhi (Ganoderma lucidum extract)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Parkinson Disease | Phase 3 | Status: UNKNOWN